Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Total synthesis of microsclerodermin E

Jidong Zhu1, Dawei Ma

  • 1State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 354 Fenglin Lu, Shanghai 200032, China.

Angewandte Chemie (International Ed. in English)
|November 13, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Copper-Catalyzed Arylation of Diverse N-Heterocycles with (Hetero)aryl Chlorides.

Organic letters·2026
Same author

Integrating Single-Cell Profiling with Generative AI for <i>De Novo</i> Design of MMP9 Protein Binders in Diffuse Large B-Cell Lymphoma.

Molecules (Basel, Switzerland)·2026
Same author

Enantioselective Total Syntheses of (+)-Aconicarmichinium C and (+)-Pendulumine I: Strategic Use of a Bridgehead Enone via a Kinetic-Resolution-Enabled Intermolecular Diels-Alder Reaction.

Journal of the American Chemical Society·2026
Same author

Phase separation-based HTS identifies cobimetinib as a YAP-TEAD inhibitor that suppresses hyperactivated YAP-induced cancer progression.

Science translational medicine·2026
Same author

2<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitors.

Journal of enzyme inhibition and medicinal chemistry·2026
Same author

Structure-Based Design of Potent and Highly Selective NUAK1 Inhibitors by Exploiting a Unique Glutamate Switch for the Prevention of Tumor Growth, Migration, and Invasion.

Journal of medicinal chemistry·2026